• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA studies show nearly half of LASIK patients report problems

FDA studies show nearly half of LASIK patients report problems

October 21, 2014 By Brad Perriello

FDA: Studies show nearly half of LASIK patients report problems

Some 45% of patients who had a laser eye surgery called LASIK later reported at least 1 visual symptom 3 months after the procedure, the FDA said yesterday.

The reported problems included difficulty driving at night or in sunshine, starbursts, glare, ghosting, halos and severe dry eye, according to the FDA. The watchdog agency said it once intended to run a 2,500-patient study, but the results from its initial Prowl-1 and Prowl-2 programs indicated that "a very large clinical study would be necessary to more accurately estimate the prevalence and find useful predictors for these patients, because there are so few."

"The FDA is unable to conduct a study of such size, although we are pleased to have our questionnaire available to researchers interested in this area," the agency said. The FDA ran the "LASIK Quality of Life Collaboration Project" along with the National Eye Institute and the U.S. Defense Dept.

Although the Prowl studies found that less than 1% of patients had difficulty with their usual activities after LASIK surgery, they showed that up 35% of patients reported halos after a LASIK procedure, the most common reported problem. Up to 30% who had no dry eye symptoms before the surgery reported dry eye symptoms afterward, according to the FDA.

In the Prowl-1 phase, a questionnaire was given to 262 patients treated at the U.S. Naval Medical Center in San Diego with standardized LASIK procedures. Another 312 patients were given the questionnaire as part of the Prowl-2 investigation of a civilian population,according to the safety bureau.

In July, the FDA denied a petition by former staffer Morris Waxler, who led the FDA team that 1st approved LASIK, seeking to have the approval revoked and initiate a recall.

Filed Under: Food & Drug Administration (FDA), News Well, Optical/Ophthalmic Tagged With: Clinical Trials, defensedepartment, Laser/Light-based Devices, National Eye Institute

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy